| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b24a5aff49d52205d2206597c8cbbb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8cde1ce093b94b621f2faf21b7a4c4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c972cb8a895ea649e7d8b5ae7292bd8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-44 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56905
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2014-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43cec4e5ac5449287080f08730748571
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65d8e64d555d4d47ea8bd9029ca2ed0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07f8d33629abf2fc7acc969ac835b96a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_755c2f37052771d98baf4edbf26cd972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f877060e6e26b2105783d07e6486a6 |
| publicationDate |
2015-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2015306195-A1 |
| titleOfInvention |
Hemoglobin receptor as novel vaccine for leishmaniasis |
| abstract |
The present invention in general relates Hemoglobin receptor or its part as a novel vaccine candidate against Leishmaniasis. Specifically, the present invention envisages HbR DNA for eliciting immune response in a mammal against Leishmaniasis. Additional aspect of the present invention is related to a vaccine composition for inducing immune response against Leishmaniasis in mammals. In a preferred aspect, the present invention relates to use of HbR-polypeptide as marker for diagnosis of Leishmania in kala-azar patients. |
| priorityDate |
2013-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |